Novartis to spin off Sandoz in October 2023
Novartis, the Swiss drugmaker, has announced that it will spin off its generic medicines division, Sandoz, on or around Oct. 4, subject to shareholder approval. The company said it planned to offer shareholders one Sandoz share for every five Novartis…